Urine drug screens: Considerations for the psychiatric pharmacist
GL Wilkening, GM Hale, C Ross - Mental Health Clinician, 2016 - meridian.allenpress.com
Introduction Proper psychiatric evaluation of patients necessitates that the clinician be
vigilant in ruling out secondary causes of symptoms, such as substance-induced symptoms …
vigilant in ruling out secondary causes of symptoms, such as substance-induced symptoms …
Urine drug screens: Considerations for the psychiatric pharmacist.
GL Wilkening, GM Hale, C Ross - The Mental Health Clinician, 2016 - europepmc.org
Methods A literature review was conducted to identify false positive UDSs associated with
psychiatric medications. References for each article identified were also reviewed …
psychiatric medications. References for each article identified were also reviewed …
[PDF][PDF] Urine drug screens: Considerations for the psychiatric pharmacist
GL Wilkening, PDGM Hale - pdfs.semanticscholar.org
Introduction: Proper psychiatric evaluation of patients necessitates that the clinician be
vigilant in ruling out secondary causes of symptoms, such as substance-induced symptoms …
vigilant in ruling out secondary causes of symptoms, such as substance-induced symptoms …
Urine Drug Screens: Considerations for the Psychiatric Pharmacist
LG Wilkening, GM Hale, C Ross - Ment Health Clin, 2016 - nsuworks.nova.edu
Introduction: Proper psychiatric evaluation of patients necessitates that the clinician be
vigilant in ruling out secondary causes of symptoms, such as substance-induced symptoms …
vigilant in ruling out secondary causes of symptoms, such as substance-induced symptoms …
[PDF][PDF] Urine drug screens: Considerations for the psychiatric pharmacist
GL Wilkening, PDGM Hale - researchgate.net
Introduction: Proper psychiatric evaluation of patients necessitates that the clinician be
vigilant in ruling out secondary causes of symptoms, such as substance-induced symptoms …
vigilant in ruling out secondary causes of symptoms, such as substance-induced symptoms …
[HTML][HTML] Urine drug screens: Considerations for the psychiatric pharmacist
GL Wilkening, GM Hale, C Ross - The Mental Health Clinician, 2016 - ncbi.nlm.nih.gov
Methods: A literature review was conducted to identify false positive UDSs associated with
psychiatric medications. References for each article identified were also reviewed …
psychiatric medications. References for each article identified were also reviewed …
Urine drug screens: Considerations for the psychiatric pharmacist
GL Wilkening, GM Hale, C Ross - The mental health …, 2016 - pubmed.ncbi.nlm.nih.gov
Introduction Proper psychiatric evaluation of patients necessitates that the clinician be
vigilant in ruling out secondary causes of symptoms, such as substance-induced symptoms …
vigilant in ruling out secondary causes of symptoms, such as substance-induced symptoms …
Urine drug screens: Considerations for the psychiatric pharmacist.
GL Wilkening, GM Hale, C Ross - The Mental Health Clinician, 2016 - europepmc.org
Methods A literature review was conducted to identify false positive UDSs associated with
psychiatric medications. References for each article identified were also reviewed …
psychiatric medications. References for each article identified were also reviewed …